About Dutas 0.
Dutas 0.5mg is a pharmaceutical-grade 5α-reductase inhibitor manufactured by Dr. Reddy’s Laboratories for laboratory research applications. Each capsule contains 0.5mg of dutasteride, a dual-type 5α-reductase inhibitor that blocks both type I and type II isoforms of the enzyme responsible for converting testosterone to dihydrotestosterone (DHT). This compound represents an important tool for researchers investigating androgen metabolism pathways and hormonal regulation mechanisms in controlled laboratory settings. The pharmaceutical formulation ensures consistent dosing for reproducible research outcomes across multiple study protocols.
Laboratory Applications
Researchers at Stroid UK Shop investigate Dutas 0.5mg capsules for studying DHT suppression mechanisms and androgenic pathway modulation. The compound’s dual inhibition profile makes it valuable for examining metabolic differences between type I and type II 5α-reductase enzymes in various tissue models. Studies examine its effects on hormonal feedback loops and androgen-sensitive cellular responses. Research applications include investigating prostate biology, hair follicle physiology, and sebaceous gland function in laboratory environments. The pharmaceutical-grade formulation supports researchers working with general health research compounds, while those studying hormone modulation may also examine selective androgen receptor modulators and peptide research compounds for comprehensive endocrine system analysis.
Product Specifications
| Active Ingredient | Dutasteride 0.5mg |
|---|---|
| Manufacturer | Dr. Reddy’s Laboratories |
| Formulation | Oral capsules |
| CAS Number | 164656-23-9 |
| Molecular Formula | C₂₇H₃₀F₆N₂O₂ |
| Storage Requirements | Room temperature, dry conditions |
| Research Applications | 5α-reductase inhibition studies |
Compliance Statement
Dutas 0.5mg capsules are supplied exclusively for in-vitro laboratory research purposes and are not intended for human consumption, clinical use, or therapeutic applications. Researchers must maintain appropriate laboratory protocols and safety measures when handling this pharmaceutical research compound.
